Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 21 studies | 55% ± 20% | |
ciliated cell | 17 studies | 38% ± 17% | |
epithelial cell | 17 studies | 60% ± 24% | |
type I pneumocyte | 11 studies | 36% ± 16% | |
secretory cell | 11 studies | 63% ± 19% | |
goblet cell | 11 studies | 43% ± 18% | |
type II pneumocyte | 10 studies | 27% ± 9% | |
club cell | 10 studies | 47% ± 21% | |
respiratory goblet cell | 8 studies | 58% ± 12% | |
enterocyte | 7 studies | 35% ± 16% | |
progenitor cell | 6 studies | 50% ± 20% | |
transit amplifying cell | 6 studies | 43% ± 22% | |
mucus secreting cell | 6 studies | 29% ± 6% | |
intestinal crypt stem cell | 5 studies | 44% ± 19% | |
keratinocyte | 5 studies | 47% ± 23% | |
deuterosomal cell | 4 studies | 35% ± 11% | |
duct epithelial cell | 4 studies | 56% ± 10% | |
squamous epithelial cell | 4 studies | 60% ± 13% | |
fibroblast | 4 studies | 21% ± 5% | |
hillock cell | 3 studies | 61% ± 8% | |
ionocyte | 3 studies | 23% ± 7% | |
brush cell | 3 studies | 41% ± 19% | |
serous secreting cell | 3 studies | 40% ± 26% | |
luminal cell of prostate epithelium | 3 studies | 53% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 60% | 3082.59 | 216 / 359 | 97% | 328.52 | 276 / 286 |
thymus | 67% | 2084.14 | 435 / 653 | 82% | 85.39 | 499 / 605 |
lung | 57% | 2228.26 | 329 / 578 | 92% | 201.01 | 1064 / 1155 |
intestine | 46% | 7407.04 | 440 / 966 | 98% | 348.75 | 519 / 527 |
esophagus | 40% | 11869.27 | 576 / 1445 | 99% | 405.25 | 182 / 183 |
bladder | 43% | 4681.33 | 9 / 21 | 94% | 286.52 | 474 / 504 |
prostate | 66% | 3196.72 | 162 / 245 | 42% | 28.36 | 211 / 502 |
ureter | 0% | 0 | 0 / 0 | 100% | 231.77 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 274.99 | 44 / 45 |
pancreas | 6% | 159.42 | 19 / 328 | 90% | 188.06 | 161 / 178 |
ovary | 0% | 0 | 0 / 180 | 92% | 99.55 | 394 / 430 |
uterus | 5% | 373.56 | 8 / 170 | 86% | 292.16 | 394 / 459 |
skin | 75% | 21288.38 | 1357 / 1809 | 6% | 4.02 | 28 / 472 |
breast | 28% | 1057.81 | 129 / 459 | 21% | 19.19 | 230 / 1118 |
muscle | 34% | 1044.46 | 270 / 803 | 0% | 0 | 0 / 0 |
kidney | 13% | 350.16 | 12 / 89 | 11% | 10.02 | 102 / 901 |
adipose | 11% | 324.71 | 134 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 9% | 8.65 | 36 / 406 |
brain | 5% | 133.49 | 123 / 2642 | 0% | 0.06 | 1 / 705 |
adrenal gland | 3% | 128.33 | 8 / 258 | 0% | 0.31 | 1 / 230 |
eye | 0% | 0 | 0 / 0 | 3% | 1.85 | 2 / 80 |
blood vessel | 1% | 35.24 | 11 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 14.92 | 3 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 6.94 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0001525 | Biological process | angiogenesis |
GO_0014816 | Biological process | skeletal muscle satellite cell differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0099156 | Biological process | cell-cell signaling via exosome |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0014908 | Biological process | myotube differentiation involved in skeletal muscle regeneration |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0032534 | Biological process | regulation of microvillus assembly |
GO_0030033 | Biological process | microvillus assembly |
GO_0061586 | Biological process | positive regulation of transcription by transcription factor localization |
GO_0060576 | Biological process | intestinal epithelial cell development |
GO_1902895 | Biological process | positive regulation of miRNA transcription |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_0014901 | Biological process | satellite cell activation involved in skeletal muscle regeneration |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0043426 | Molecular function | MRF binding |
GO_0005515 | Molecular function | protein binding |
Gene name | KLF5 |
Protein name | Epididymis secretory sperm binding protein (Kruppel-like factor 5 (Intestinal)) Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2) |
Synonyms | IKLF BTEB2 CKLF hCG_32789 |
Description | FUNCTION: Transcription factor that binds to GC box promoter elements. Activates the transcription of these genes. |
Accessions | ENST00000539231.5 [Q13887-4] Q5T6X2 Q13887 ENST00000377687.6 [Q13887-1] |